Richard W. Rew II's Net Worth
$6.17 Million
Who is Richard W. Rew II?
Richard W. Rew II has an estimated net worth of $6.17 Million. This is based on reported shares across multiple companies, which include IsoPlexis Corp, Tabula Rasa HealthCare, Inc., ARTHROCARE CORP, and LUMINEX CORP.
SEC CIK
Richard W. Rew II's CIK is 0001433265
Past Insider Trading and Trends
2014 was Richard W. Rew II's most active year for acquiring shares with 11 total transactions. Richard W. Rew II's most active month to acquire stocks was the month of January. 2014 was Richard W. Rew II's most active year for disposing of shares, totalling 15 transactions. Richard W. Rew II's most active month to dispose stocks was the month of June. 2006 saw Richard W. Rew II paying a total of $1,761,605.00 for 45,000 shares, this is the most they've acquired in one year. In 2014 Richard W. Rew II cashed out on 255,147 shares for a total of $7,849,814.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IsoPlexis Corp No price found
SVP, GC and SecretaryRichard W. Rew II used to own units in Common Stock but no longer holds any shares there. In the year 2021 Richard W. Rew II filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.00K |
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
∞
| 20K |
$1.99 | $39,800.00 | 20K |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tabula Rasa HealthCare, Inc. (TRHC) No price found
CHIEF LEGAL OFFICER, SECRETARYRichard W. Rew II used to own units in Common Stock but no longer holds any shares there. In the year 2023 Richard W. Rew II filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -63.66K |
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
∞
| 25.46K |
—
|
—
| 25.46K |
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARTHROCARE CORP No price found
Senior VP & General CounselRichard W. Rew II used to own units in Common Stock but no longer holds any shares there. From 2008 to 2014 Richard W. Rew II acquired a total of 149,893 shares in ARTHROCARE CORP at a cost of $2,908,498.39, Richard also disposed a total of 154,039 shares of ARTHROCARE CORP equalling to $7,594,011.95.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -36.89K |
$37.74 | -$4,251,947.03 |
0
|
May 29
| |||
Form 4
| +13.75% | 4.37K |
$42.47 | -$26,960.80 | 36.14K |
Feb 26
| |||
Form 4
| +18.63% | 5.08K |
—
| $5.08 | 32.35K |
Feb 20
| |||
Form 4
| +20.23% | 4.63K |
$26.23 | -$2,146.14 | 27.54K |
Feb 27 - Feb 28
| |||
Form 4
| +22.48% | 4.2K |
—
| $4.20 | 22.91K |
Feb 17
| |||
Form 4
| +123.84% | 13.7K |
$41.06 | -$441,030.79 | 24.77K |
Jul 31 - Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUMINEX CORP No price found
SVP, Gen Counsel & Corp SecyRichard W. Rew II used to own units in Common Stock but no longer holds any shares there. From 2015 to 2021 Richard W. Rew II acquired a total of 80,586 shares in LUMINEX CORP at a cost of $1,642,220.42, Richard also disposed a total of 84,717 shares of LUMINEX CORP equalling to $3,162,815.43.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -47.58K |
$37.00 | -$1,760,312.00 |
0
|
Jul 14
| |||
Form 4
| +20.92% | 13.7K |
$32.72 | $448,805.17 | 79.17K |
Mar 11 - Mar 12
| |||
Form 4
|
—
|
0
|
$27.93 | -$536,425.00 | 33.15K |
Scheduled
|
Aug 3 - Aug 5
| ||
Form 4
|
—
|
0
|
$26.43 | -$234,675.00 | 77.14K |
Scheduled
|
Jul 17
| ||
Form 4
| +15.72% | 7.62K |
$23.56 | $174,713.72 | 56.07K |
Mar 11 - Mar 12
| |||
Form 4
| +19.85% | 6.77K |
$24.38 | $165,525.51 | 40.89K |
Mar 11 - Mar 12
| |||
Form 4
| +46.21% | 8.01K |
$21.86 | $176,089.59 | 25.34K |
Mar 10 - Mar 12
| |||
Form 4
| +134.16% | 4.85K |
—
|
—
| 8.46K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +325.52% | 2.5K |
$18.27 | $45,683.00 | 3.27K |
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||